Tropical Weight Loss
Tropical Weight Loss
Photo: Ono Kosuki
Diagnostic accuracy of SmartPill GET to the curve obtained from gastric emptying scintigraphy between gastroparetics and healthy subjects was 0.83. The study concluded that SmartPill correlated well with gastric emptying scintigraphy and accurately discriminates between healthy subjects and those with gastroparesis.
about 6 months Research shows that weight loss plateaus happen after about 6 months of following a low calorie diet. Doctors are unsure why weight...
Read More »
The bulging lower abdominal problem commonly occurs in women after childbirth, but may also effect men and women who haven't experienced pregnancy....
Read More »Our data using the SmartPill indicate that transit times are prolonged in persons with SCI, which is consistent with previous findings using more invasive assessment techniques. As in the AB population, the present approach is arguably the most non-invasive method of determining GI transit times after SCI. Nevertheless, our results appear to confirm prior technology involving ingested radiopaque markers and indwelling manometry catheters. Although the primary intent of this study was to assess the application of this technology to a unique subgroup of persons, our results, nonetheless, may have implications in terms of the pathogenesis of gastroesophageal reflux disease, constipation and fecal impactions after SCI. Gastroesophageal reflux disease has been associated with multiple potential causes, including delayed gastric emptying, lower esophageal sphincter dysfunction, lifestyle factors including obesity and smoking, supine or recumbent positioning, and excess gastric acidity. This study has evaluated asymptomatic patients with SCI. Although gastric emptying of the SmartPill may not be an exact representation of physiologic gastric emptying of a mixed solid and liquid meal, given that all subjects followed the same testing procedures, we are clearly able to demonstrate that gastric emptying is, in fact, delayed in paraplegic and tetraplegic patients, relative to our control group. Similar findings using radiolabeled solid and liquid meals are found in the literature.5, 6 A study conducted by Zhang et al.7 found conflicting findings, suggesting that SCI does not affect gastric emptying. However, the consensus of the literature, including the present data, indicates that gastric emptying is, in fact, delayed in this population. An increased incidence of constipation and impactions in patients with SCI is a well-known medical consequence of SCI. Despite extensive lifestyle modifications, medical interventions and regular, invasive bowel care techniques, many patients with SCI continue to have bowel dysfunction.8 It is known that decreased sacral parasympathetic innervations and colonic motility can result in prolonged CTT.9 Our data support previous findings (using less advanced technology) and demonstrate that CTT is delayed in both paraplegic and tetraplegic patients, with no significant difference between the two subgroups.10, 11 The colon is largely responsible for absorption of water from digestive waste, and prolonged colonic transit may result in hardened stool and subsequent constipation or impaction. All subjects enrolled in this study successfully ingested and excreted the SmartPill capsule without side effects or complications, including esophageal or intestinal obstruction. All subjects with SCI, even those with high-level cervical lesions, were able to swallow the capsule without undue distress. All subjects reported that they would undergo the evaluation again in the future, if necessary, and no subjects reported complications or side effects of any kind. Therefore, no adverse side effects were observed during this study. However, several factors should be taken into consideration prior to adopting this technology for clinical use. There is a high initial investment for the SmartPill software and each capsule is an additional expense. In conclusion, SmartPill is a safe, valid approach and we can confidently support the use of this technology for future GI investigations in persons with SCI. Additionally, our SmartPill data seem to indicate that gastric emptying, colonic and cumulative WGTTs are prolonged in persons with SCI.
Here are some of the benefits of Goli Gummy: IT CAN HELP YOU LOSE WEIGHT & REDUCE BELLY FAT. IT CAN HELP LOWER CHOLESTEROL & IMPROVE HEART HEALTH....
Read More »
the morning In order to lose weight, you can consume 2 glasses of warm lemon water, i.e. once in the morning and once in the evening. You can also...
Read More »Plenity (cellulose and citric acid) is an oral capsule that promotes fullness and may help to increase satiety to help patients manage their weight and is indicated to aid in weight management in overweight and obese adults with a Body Mass Index (BMI) of 25-40 kg/m2, when used in conjunction with diet and exercise.
5 ways to boost metabolism Exercise more. Add interval training to your cardio routine and burn more calories in less time. ... Weight train. Add...
Read More »
Symptoms Feeling more thirsty than usual. Urinating often. Losing weight without trying. Presence of ketones in the urine. ... Feeling tired and...
Read More »
Intermittent fasting may help your body reach ketosis quicker than the keto diet alone. That's because your body, when fasting, maintains its...
Read More »
Generally, patients lose about one or two sizes on their clothing following a tummy tuck procedure. However, the unique changes in each patient's...
Read More »
Promotion
Promotion
Promotion
